Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2017

Nov 7, 2017

29995_dirs_2017-11-07_f3d030db-e5b3-4caf-97f6-0115c8b434c9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2017-11-03

Reporting Person: Townsend Christopher G (President, Asia)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-03 Common Stock M 49660 $27.19 Acquired 49660 Direct
2017-11-03 Common Stock S 49660 $54.605 Disposed 0 Direct
2017-11-03 Common Stock M 33071 $31.15 Acquired 33071 Direct
2017-11-03 Common Stock S 33071 $54.602 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-11-03 Employee Stock Option (Right to Buy) $27.19 M 49660 Disposed 2022-07-31 Common Stock (49660) Direct
2017-11-03 Employee Stock Option (Right to Buy) $31.15 M 33071 Disposed 2023-02-25 Common Stock (33071) Direct

Footnotes

F1: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

F2: The shares were sold in multiple transactions at prices $54.560 to $54.630, inclusive.

F3: The shares were sold in multiple transactions at prices $54.600 to $54.618, inclusive.

F4: The options became exercisable in three equal installments on August 1, 2013, 2014 and 2015.

F5: The options became exercisable in three equal installments on February 26, 2014, 2015 and 2016.